Randomized controlled trials are the ‘gold standard’ of research — but a difficult fit for trans care
In order to provide gender-affirming care, clinicians must sometimes jump through unusual hoops.
In Australia, for example, the government won’t subsidize testosterone treatment for a trans man without a peculiar bureaucratic maneuver; a doctor must say the patient has a testicular disorder. The disorder: Trans men, being trans, are born without testes.
